Sari Tuupanen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sari Tuupanen has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Lauri A. Aaltonen
Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland
2 shared publications - Auli Karhu
Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland
1 shared publication Heikki Järvinen
Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland
1 shared publication- Heikki Järvinen
Department of Surgery, Helsinki University Central Hospital, P.O Box 340 (Haartmaninkatu 4), Helsinki, Finland, FIN-00029
1 shared publication Heli J. Lehtonen
Department of Medical Genetics, Genome-Scale Biology Research Program, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland
1 shared publication- Ian Tomlinson
University of Oxford
1 shared publication
Latest Publications
- 1 December 2012
- Published by Elsevier in Gastroenterology
- Vol. 143 (6) , 1482-1491.e3
Segregation of a Missense Variant in Enteric Smooth Muscle Actin γ-2 With Autosomal Dominant Familial Visceral Myopathy
- 1 December 2012
- Published by Elsevier in Gastroenterology
- Vol. 143 (6) , 1482-1491.e3
Segregation of a Missense Variant in Enteric Smooth Muscle Actin γ-2 With Autosomal Dominant Familial Visceral Myopathy
- Open Access
- 14 February 2011
- Published by Springer Nature in BMC Medical Genetics
- Vol. 12 (1) , 23
Systematic search for enhancer elements and somatic allelic imbalance at seven low-penetrance colorectal cancer predisposition loci
Common single-nucleotide polymorphisms (SNPs) in ten chromosomal loci have been shown to predispose to colorectal cancer (CRC) in genome-wide association studies. A plausible biological mechanism of CRC susceptibility associated with genetic variation has so far only been proposed for three loci, each pointing to variants that affect gene expression through distant regulatory elements. In this study, we aimed to gain insight into the molecular basis of seven low-penetrance CRC loci tagged by rs4779584 at 15q13, rs10795668 at 10p14, rs3802842 at 11q23, rs4444235 at 14q22, rs9929218 at 16q22, rs10411210 at 19q13, and rs961253 at 20p12. Possible somatic gain of the risk allele or loss of the protective allele was studied by analyzing allelic imbalance in tumour and corresponding normal tissue samples of heterozygous patients. Functional variants were searched from in silico predicted enhancer elements locating inside the CRC-associating linkage-disequilibrium regions. No allelic imbalance targeting the SNPs was observed at any of the seven loci. Altogether, 12 SNPs that were predicted to disrupt potential transcription factor binding sequences were genotyped in the same population-based case-control series as the seven tagging SNPs originally. None showed association with CRC. The results of the allelic imbalance analysis suggest that the seven CRC risk variants are not somatically selected for in the neoplastic progression. The bioinformatic approach was unable to pinpoint cancer-causing variants at any of the seven loci. While it is possible that many of the predisposition loci for CRC are involved in control of gene expression by targeting transcription factor binding sites, also other possibilities, such as regulatory RNAs, should be considered.
- 14 February 2011
- Published by Springer Nature in BMC Medical Genetics
- Vol. 12 (1) , 23
Open AccessSystematic search for enhancer elements and somatic allelic imbalance at seven low-penetrance colorectal cancer predisposition loci
Common single-nucleotide polymorphisms (SNPs) in ten chromosomal loci have been shown to predispose to colorectal cancer (CRC) in genome-wide association studies. A plausible biological mechanism of CRC susceptibility associated with genetic variation has so far only been proposed for three loci, each pointing to variants that affect gene expression through distant regulatory elements. In this study, we aimed to gain insight into the molecular basis of seven low-penetrance CRC loci tagged by rs4779584 at 15q13, rs10795668 at 10p14, rs3802842 at 11q23, rs4444235 at 14q22, rs9929218 at 16q22, rs10411210 at 19q13, and rs961253 at 20p12. Possible somatic gain of the risk allele or loss of the protective allele was studied by analyzing allelic imbalance in tumour and corresponding normal tissue samples of heterozygous patients. Functional variants were searched from in silico predicted enhancer elements locating inside the CRC-associating linkage-disequilibrium regions. No allelic imbalance targeting the SNPs was observed at any of the seven loci. Altogether, 12 SNPs that were predicted to disrupt potential transcription factor binding sequences were genotyped in the same population-based case-control series as the seven tagging SNPs originally. None showed association with CRC. The results of the allelic imbalance analysis suggest that the seven CRC risk variants are not somatically selected for in the neoplastic progression. The bioinformatic approach was unable to pinpoint cancer-causing variants at any of the seven loci. While it is possible that many of the predisposition loci for CRC are involved in control of gene expression by targeting transcription factor binding sites, also other possibilities, such as regulatory RNAs, should be considered.